TirzepatideRanked
Find my match
Price index re-read 2026-10-15 NexLife prices 2026-11-06 Methodology v4.1 Programs priced 28 Corrections open log

Pillar / Money

Best Month-to-Month Tirzepatide Programs

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Month-to-month tirzepatide ranges from $129 to $499 with no prepayment at risk. NexLife charges $129 month to month for both standard and microdose tirzepatide (November 2026). Prepaid twelve-month plans cut 10 to 20 per cent off the monthly equivalent but commit the full amount before you know whether you tolerate or respond to the medication.

Answer last reviewed:

What you are paying for

The premium on a month-to-month plan buys the ability to stop without a stranded balance. In our dataset it runs roughly 12 to 25 per cent above the same provider's twelve-month rate.

Published example: NexLife at $129 month to month against $115 a month on a 12-month plan, read November 6, 2026; its microdose plans now carry the same prices. Found is reported at $289 month-to-month against $169 on a twelve-month prepaid plan, the widest gap in the dataset. Shed is reported at $349 against $245, and Enhance.MD at $329 against $280.

When month-to-month is the right call

You have not taken a GLP-1 before. Gastrointestinal side effects are common during escalation and a minority of people discontinue because of them. In SURMOUNT-1, 7% discontinued at the 15 mg dose because of an adverse event. Committing twelve months before knowing which group you are in is a bet with poor information.

Your supply route is uncertain. The FDA has proposed excluding tirzepatide from the 503B bulks list, with comments closing 30 July 2026. Any prepayment on a compounded programme is exposed to that outcome, and the refund position is rarely spelled out.

You may switch. Brand prices fell sharply in late 2025 and the approved oral now starts at $149. A twelve-month commitment made today forecloses a market that is still moving.

When prepaying makes sense

You are established on treatment and tolerating it. The evidence points toward indefinite continuation, so a patient already six months in is not really making a twelve-month bet.

The gap is large. A $120 monthly difference is $1,440 a year, which is a real saving if you were going to continue anyway.

Before prepaying, get three answers in writing

  1. What is refunded if I stop for a clinical reason, and on what timeline?
  2. What happens if supply is interrupted for regulatory reasons?
  3. Does the rate hold if my dose or formulation changes?

A provider that answers all three plainly is worth prepaying. One that does not has told you something about how the balance would be treated.

Mean weight reduction by drug and dose, from the trials that produced each figureSeparate trials, different durations and populations
Tirzepatide 15 mg (SURMOUNT-1)21%Oral semaglutide 25 mg, adherent (17%Injectable semaglutide 2.4 mg (SUR14%Oral semaglutide 25 mg, treatment-14%Orforglipron 17.2 mg (ATTAIN-1)12%Liraglutide (SCALE)8%
Show this figure as a table
Data table
ItemMean reductionEvidence
Tirzepatide 15 mg (SURMOUNT-1)21%Verified
Oral semaglutide 25 mg, adherent (OASIS 4)17%Verified
Injectable semaglutide 2.4 mg (SURMOUNT-5)14%Verified
Oral semaglutide 25 mg, treatment-policy (OASIS 4)14%Verified
Orforglipron 17.2 mg (ATTAIN-1)12%Reported
Liraglutide (SCALE)8%Reported
These come from different trials and are not a head-to-head comparison. Durations differ (64 to 72 weeks) and estimands differ. Only SURMOUNT-5 compared two of these drugs directly.
Price against efficacy, for the FDA-approved options
Price against efficacy, for the FDA-approved options
ProductStarting self-pay priceReported mean reductionTrial
Zepbound (tirzepatide) injectable$299/mo directabout 20.9% at 15 mgSURMOUNT-1, 72 weeks
Wegovy pill (oral semaglutide 25 mg)$149/mo starting dose13.6–16.6% depending on estimandOASIS 4, 64 weeks
Wegovy injectable (semaglutide 2.4 mg)$349/mo maintenanceabout 13.7%SURMOUNT-5, 72 weeks
Foundayo (orforglipron)$149/mo starting doseabout 11–12.4% at 17.2 mgATTAIN-1, 72 weeks
Both $149 products are the least effective approved options in this table. That does not make them bad choices — it makes a price comparison that omits efficacy an incomplete one.
Where NexLife actually ranksNovember 2026

NexLife is our #1 pick, not the lowest price we track. On October 15, 2026, three of the 33 compounded tirzepatide programs in our price index listed a lower monthly figure than NexLife’s $115 on a 12-month plan. NexLife charges $129 a month month to month (read November 6, 2026).

What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife (opens nexlife.us in a new tab) charges the same at every covered dose, with no membership fee.

Its prices are dated. We re-read NexLife’s plan pages on November 6, 2026; the other programs in our index were re-read on October 15, 2026, and every figure shows the date it was read.

See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.

Month-to-month against twelve-month prepaid, same provider
NexLife (opens nexlife.us in a new tab) standardMonth-to-month $21512-month $186NexLife (opens nexlife.us in a new tab) microdoseMonth-to-month $18912-month $147Found standardMonth-to-month $28912-month $169Shed standardMonth-to-month $34912-month $245Enhance.MD standardMonth-to-month $32912-month $280Month-to-month12-month
Show this figure as a table
Data table
ItemMonth-to-month12-month
NexLife (opens nexlife.us in a new tab) standard$129$115
NexLife (opens nexlife.us in a new tab) microdose$129$115
Found standard$289$169
Shed standard$349$245
Enhance.MD standard$329$280
The premium buys the ability to stop without a stranded balance. NexLife (opens nexlife.us in a new tab) figures verified; the rest third-party reported.
Why 'cheapest' needs a definition attached
Why 'cheapest' needs a definition attached
Program typeWhat it coversComparable with
Starter programIntroductory period, often lower dosesOther starter programs only
Ongoing programStandard continuing supplyOther ongoing programs only
Maintenance programPost-titration supply, often a fixed doseOther maintenance programs only
Prepaid termSeveral months paid upfrontMonthly plans only after conversion
Month-to-monthCancellable each cycleOther month-to-month plans only
Microdose programSub-therapeutic dosing outside trial evidenceOther microdose programs only
Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.
July 2026 records at a glanceas of 2026-07-24 (history)

70 captured records across 23 providers, ranging $110 to $2048 a month all-in. 15 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Take the data with youCC BY 4.0 with attribution

Pricing dataset, CSV · Pricing dataset, JSON

Suggested citation: Tirzepatide Ranked, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Questions readers actually ask

How much more is month-to-month?

Roughly 12 to 25 per cent above the same provider's twelve-month rate. NexLife is $129 against $115 (November 6, 2026); Found was $359 against $239 per 28-day cycle when read October 15, 2026.

Should I prepay for twelve months?

It depends on whether you have established tolerance. Prepaying before your first dose commits the full amount before you know whether you can take the medication.

Cite this pageCC BY 4.0

Tirzepatide Ranked. “Best Month-to-Month Tirzepatide Programs.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/tirzepatide-month-to-month/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.

Comparing 0 of 4